ClinicalTrials.Veeva

Menu

The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

C

Chittagong Medical College

Status and phase

Completed
Phase 2

Conditions

To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients

Treatments

Drug: Drugs, Investigational

Study type

Interventional

Funder types

Other

Identifiers

NCT04205201
CMC/PG/2018/1828

Details and patient eligibility

About

Outpatient department of cmch, ceitc,cimch POAG patients enrolled for the study.

Enrollment

80 patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • IOP 22_34mmof Hg,newly diagnosed case, bilateral POAG patients Patients.

Exclusion criteria

  • pregnant and lactating women, infection, any eye surgery.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups

Group A
Experimental group
Description:
Latanoprost
Treatment:
Drug: Drugs, Investigational
Group B
Other group
Description:
Brimonidine
Treatment:
Drug: Drugs, Investigational

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems